Underwood Capital Limited has released a press release.
Extension of Yissum Licensing Agreement
Filed with ASX ·
6ix hasn’t read this filing yet.
Underwood Capital Limited on 6ix
Later from Underwood Capital
- Successful Results of Phase 1 Clinical Trial
- Cannabis Legalisation Gives MMJ the Green Light
- Capital Raising
- Satipharm Gelpell Outperforms Sativex in Phase 1 Trial
- Progress on MMJs Lucky Lake Facility MMPR Application
Follow Underwood Capital into a list and get an email when it puts out news.
Follow Underwood Capital